NLS Global report

An international team of researchers has identified the first genetic variant associated with disease severity in multiple sclerosis (MS). In MS, the immune system mistakenly attacks the brain and spinal cord, resulting in symptom flares known as relapses as well as longer-term degeneration, known as progression. Previous studies have identified genetic factors that increase the risk […]

The United Kingdom’s decision to leave the European Union sent shockwaves across industries, including the life sciences sector. Many companies are grappling with uncertainty and are still struggling to understand the potential implications of Brexit on their operations. Despite this, some opportunities may arise, particularly for the Nordic region, which has close links with the […]

The USA was hit hard by the COVID-19 pandemic. What insights have been made, what actions have been taken, what are the new strategies and how is the country preparing for the next one? The world has suffered immensely over the past three years as leaders have navigated their way through a never-before-seen health crisis. […]

This year’s theme was ‘Stand Up for Science’ but the world’s largest biotechnology conference covers so much more and attracted companies, investors and policy makers from around the globe – including, of course, those representing the Nordics. Although partnering is the main reason why most companies’ management team attend the event, BIO is also the […]

Novartis has entered into an agreement to acquire Chinook Therapeutics, a Seattle, WA, based clinical stage biopharmaceutical company with two high-value, late-stage medicines in development for rare, severe chronic kidney diseases. The agreed deal, which is subject to customary closing conditions, is fully in line with Novartis strategy to focus on innovative medicines and will […]

This year’s BIO international Convention is back in Boston again after 5 years in other cities or going digital during the pandemic. Considering the number of attendees (at least 18,000 from 85 countries) and exhibiting companies in a fully packed exhibition area, it feels like BIO in Boston 2018, yet significantly different in some respects. […]